Office of the Chief Science Officer; The Ethics Subcommittee of the Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), and the Public Health Ethics Committee, Office of the Chief Science Officer, CDC, 7046 [E6-1822]

Download as PDF 7046 Federal Register / Vol. 71, No. 28 / Friday, February 10, 2006 / Notices Respondents Number of respondents Number of responses per respondent Average burden per response (in hours) Project Organizations .................................................................................................................. 10 2 77/60 Betsey Dunaway, DEPARTMENT OF HEALTH AND HUMAN SERVICES both CDC and the Agency for Toxic Substances and Disease Registry. Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–1828 Filed 2–9–06; 8:45 am] Centers for Disease Control and Prevention Dated: February 6, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–1822 Filed 2–9–06; 8:45 am] Dated: February 2, 2006. Office of the Chief Science Officer; The Ethics Subcommittee of the Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), and the Public Health Ethics Committee, Office of the Chief Science Officer, CDC BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director, Centers for Disease Control and Prevention: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Advisory Committee to the Director, Centers for Disease Control and Prevention, of the Department of Health and Human Services, has been renewed for a 2-year period extending through February 1, 2008. For further information contact: Lynn Austin, Ph.D, Executive Secretary, Advisory Committee to the Director, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, NE., M/S D–14, Atlanta, Georgia 30333, telephone 404–639–7000 or fax 404/ 498–7111. The Director, Management and Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: February 2, 2006. rmajette on PROD1PC67 with NOTICES1 Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 06–1202 Filed 2–9–06; 8:45 am] BILLING CODE 4163–18–P VerDate Aug<31>2005 15:10 Feb 09, 2006 Jkt 208001 BILLING CODE 4163–18–P In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC announces the following committee meeting. Centers for Disease Control and Prevention Name: Joint Meeting of the Ethics Subcommittee, ACD, CDC, and CDC’s Public Health Ethics Committee. Time and Date: 9 a.m.–3:30 p.m., February 16, 2006. Place: CDC Global Communications Center (Building 19), 1600 Clifton Road, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 60 people. Purpose: The meeting will provide a report on the progress of CDC’s efforts to increase the capacity of public health ethics, to manage issues involving public health ethics, and to identify the current and future public health ethics needs and priorities at CDC. Matters To Be Discussed: Agenda items will include highlights of public health activities in 2005; public health ethics at CDC in 2006 and the future; a report on the Pandemic Influenza Planning consultation; public health ethics challenges (focus on science); and a discussion on needs, priorities, and action steps. Agenda items are subject to change as priorities dictate. Due to administrative issues that had to be resolved, the Federal Register notice is being published less than fifteen days before the date of the meeting. Contact Person For More Information: Jan Devier, Dr.P.H., M.P.A., Health Scientist and Senior Advisor, Science Vision and Alliances Team, Office of the Chief Science Officer, 1600 Clifton Road, NE., M.S. D–50, Atlanta, Georgia 30333. Telephone (404) 639–4690. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Committee on Immunization Practices: Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following Federal Committee meeting. Correction: To include a Vaccines for Children vote on influenza. Name: Advisory Committee on Immunization Practices (ACIP). Times and Dates: 8 a.m.–6:15 p.m., February 21, 2006. 8 a.m.–5 p.m., February 22, 2006. Place: Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Building 19, Room 232, Atlanta, Georgia 30333. For Further Information Contact: Demetria Gardner, Epidemiology and Surveillance Division, National Immunization Program, CDC, 1600 Clifton Road, NE., (E–61), Atlanta, Georgia 30333, telephone 404/639–8096, fax 404/639–8616. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 6, 2006. Alvin Hall, Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E6–1823 Filed 2–9–06; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 71, Number 28 (Friday, February 10, 2006)]
[Notices]
[Page 7046]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-1822]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Office of the Chief Science Officer; The Ethics Subcommittee of 
the Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention (CDC), and the Public Health Ethics Committee, 
Office of the Chief Science Officer, CDC

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC announces the following committee 
meeting.

    Name: Joint Meeting of the Ethics Subcommittee, ACD, CDC, and 
CDC's Public Health Ethics Committee.
    Time and Date: 9 a.m.-3:30 p.m., February 16, 2006.
    Place: CDC Global Communications Center (Building 19), 1600 
Clifton Road, Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 60 people.
    Purpose: The meeting will provide a report on the progress of 
CDC's efforts to increase the capacity of public health ethics, to 
manage issues involving public health ethics, and to identify the 
current and future public health ethics needs and priorities at CDC.
    Matters To Be Discussed: Agenda items will include highlights of 
public health activities in 2005; public health ethics at CDC in 
2006 and the future; a report on the Pandemic Influenza Planning 
consultation; public health ethics challenges (focus on science); 
and a discussion on needs, priorities, and action steps.
    Agenda items are subject to change as priorities dictate.
    Due to administrative issues that had to be resolved, the 
Federal Register notice is being published less than fifteen days 
before the date of the meeting.
    Contact Person For More Information: Jan Devier, Dr.P.H., 
M.P.A., Health Scientist and Senior Advisor, Science Vision and 
Alliances Team, Office of the Chief Science Officer, 1600 Clifton 
Road, NE., M.S. D-50, Atlanta, Georgia 30333. Telephone (404) 639-
4690.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.


    Dated: February 6, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-1822 Filed 2-9-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.